Terms: = Ovarian cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Diagnosis
19 results:
1. Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer.
Sonigo C; Amsellem N; Mayeur A; Laup L; Pistilli B; Delaloge S; Eustache F; Sifer C; Rakrouki S; Benoit A; Peigné M; Grynberg M
Fertil Steril; 2023 Mar; 119(3):465-473. PubMed ID: 36473609
[TBL] [Abstract] [Full Text] [Related]
2. Urokinase Plasminogen Activator Receptor-Mediated Targeting of a Stable Nanocomplex Coupled with Specific Peptides for Imaging of cancer.
Shahdeo D; Chandra AB; Gandhi S
Anal Chem; 2021 Aug; 93(34):11868-11877. PubMed ID: 34410104
[TBL] [Abstract] [Full Text] [Related]
3. Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to up-regulate ZEB1 and MDM2.
Zhang F; Xu Y; Ye W; Jiang J; Wu C
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667627
[TBL] [Abstract] [Full Text] [Related]
4. Double heterozygous mutation in the BRCA1 and ATM genes involved in development of primary metachronous tumours: a case report.
Andrés R; Menao S; Arruebo M; Quílez E; Cardiel MJ
Breast Cancer Res Treat; 2019 Oct; 177(3):767-770. PubMed ID: 31292799
[TBL] [Abstract] [Full Text] [Related]
5. Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study.
Laasik M; Kemppainen J; Auranen A; Hietanen S; Grénman S; Seppänen M; Hynninen J
Cancer Imaging; 2019 May; 19(1):27. PubMed ID: 31142357
[TBL] [Abstract] [Full Text] [Related]
6. Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of ovarian cancer Screening (UKCTOCS).
Thomas DS; Gentry-Maharaj A; Ryan A; Fourkala EO; Apostolidou S; Burnell M; Alderton W; Barnes J; Timms JF; Menon U
Cancer Epidemiol; 2019 Feb; 58():167-174. PubMed ID: 30616086
[TBL] [Abstract] [Full Text] [Related]
7. The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study.
Delgado-Ortega L; González-Domínguez A; Borrás JM; Oliva-Moreno J; González-Haba E; Menjón S; Pérez P; Vicente D; Cordero L; Jiménez M; Simón S; Hidalgo-Vega Á; Moya-Alarcón C
Eur J Health Econ; 2019 Feb; 20(1):135-147. PubMed ID: 29922900
[TBL] [Abstract] [Full Text] [Related]
8. A prospective study of mitochondrial DNA copy number and the risk of prostate cancer.
Moore A; Lan Q; Hofmann JN; Liu CS; Cheng WL; Lin TT; Berndt SI
Cancer Causes Control; 2017 Jun; 28(6):529-538. PubMed ID: 28357528
[TBL] [Abstract] [Full Text] [Related]
9. Long-Term Secondary Care Costs of Endometrial cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of ovarian cancer Screening (UKCTOCS).
Pennington M; Gentry-Maharaj A; Karpinskyj C; Miners A; Taylor J; Manchanda R; Iyer R; Griffin M; Ryan A; Jacobs I; Menon U; Legood R
PLoS One; 2016; 11(11):e0165539. PubMed ID: 27829038
[TBL] [Abstract] [Full Text] [Related]
10. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract] [Full Text] [Related]
11. Prevalence of the blm nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe.
Bogdanova N; Togo AV; Ratajska M; Kluźniak W; Takhirova Z; Tarp T; Prokofyeva D; Bermisheva M; Yanus GA; Gorodnova TV; Sokolenko AP; Kuźniacka A; Podolak A; Stukan M; Wokołorczyk D; Gronwald J; Vasilevska D; Rudaitis V; Runnebaum IB; Dürst M; Park-Simon TW; Hillemanns P; Antonenkova N; Khusnutdinova E; Limon J; Lubinski J; Cybulski C; Imyanitov E; Dörk T
Fam Cancer; 2015 Mar; 14(1):145-9. PubMed ID: 25182961
[TBL] [Abstract] [Full Text] [Related]
12. Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines.
Zhang S; Zhou X; Yu H; Yu Y
BMC Cancer; 2010 Apr; 10():163. PubMed ID: 20423514
[TBL] [Abstract] [Full Text] [Related]
13. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.
Wang-Johanning F; Liu J; Rycaj K; Huang M; Tsai K; Rosen DG; Chen DT; Lu DW; Barnhart KF; Johanning GL
Int J Cancer; 2007 Jan; 120(1):81-90. PubMed ID: 17013901
[TBL] [Abstract] [Full Text] [Related]
14. [Small bowel metastases from lung cancer].
Cipollone G; Santarelli G; Quitadamo S; Iarussi T; Mucilli F
Chir Ital; 2004; 56(5):639-48. PubMed ID: 15553434
[TBL] [Abstract] [Full Text] [Related]
15. [Significance of concentration of serum soluble vascular cell adhesion molecule-1 in epithelial ovarian carcinoma].
Qiao XM; Wang ZM
Ai Zheng; 2004 Jan; 23(1):81-4. PubMed ID: 14720381
[TBL] [Abstract] [Full Text] [Related]
16. [Radiological diagnosis of splenic metastasis and its prevalence at autopsy].
Imada H; Nakata H; Horie A
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 May; 51(5):498-503. PubMed ID: 1651470
[TBL] [Abstract] [Full Text] [Related]
17. Malignant lymphoma antigen expressed in nude mouse tumor cells derived from carcinogen-transformed Bloom's syndrome B-lymphoblastoid cell lines.
Shiraishi Y; Moriki T; Hara H; Araki K; Kozuru M; Sandberg AA
Cancer Res; 1990 May; 50(10):3106-12. PubMed ID: 2185881
[TBL] [Abstract] [Full Text] [Related]
18. cancer antigens are expressed in a carcinogen-transformed Bloom syndrome B-lymphoblastoid cell line.
Shiraishi Y; Soma H
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8211-5. PubMed ID: 3186719
[TBL] [Abstract] [Full Text] [Related]
19. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract] [Full Text] [Related]
